Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Brincidofovir

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Emergent BioSolutions Executes Contract Options For TEMBEXA
    Emergent BioSolutions Executes Contract Options For TEMBEXA

    26 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/26/2953776/33240/en/Emergent-BioSolutions-Announces-the-Execution-of-Contract-Options-Valued-at-67-4-Million-to-Procure-Additional-TEMBEXA-brincidofovir-to-Support-National-Preparedness-Efforts.html

    GLOBENEWSWIRE
    26 Sep 2024
    Share Share
    Emergent closes on buying smallpox drug Tembexa from Chimerix
    Emergent closes on buying smallpox drug Tembexa from Chimerix

    28 Sep 2022

    // Tyler Patchen ENDPTS

    https://endpts.com/emergent-closes-on-buying-smallpox-drug-tembexa-from-chimerix-with-a-238m-payment/

    Tyler Patchen ENDPTS
    28 Sep 2022
    Share Share
    Emergent acquires global rights for oral smallpox antiviral from Chimerix
    Emergent acquires global rights for oral smallpox antiviral from Chimerix

    27 Sep 2022

    // PHARMACEUTICAL-TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/emergent-smallpox-antiviral/

    PHARMACEUTICAL-TECHNOLOGY
    27 Sep 2022
    Share Share
    Chimerix Announces TEMBEXA Procurement Agreement for Approximately $25.3M
    Chimerix Announces TEMBEXA Procurement Agreement for Approximately $25.3M

    24 Jun 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/06/24/2468864/25619/en/Chimerix-Announces-TEMBEXA-Procurement-Agreement-for-Approximately-25-3-Million-with-Public-Health-Agency-of-Canada.html

    GLOBENEWSWIRE
    24 Jun 2022
    Share Share
    Emergent adds another arrow to its medical ountermeasures quiver
    Emergent adds another arrow to its medical ountermeasures quiver

    16 May 2022

    // Fraiser Kansteiner FIERCEPHARMA

    https://www.fiercepharma.com/pharma/emergent-beefs-countermeasure-repertoire-325m-deal-chimerixs-smallpox-newcomer-tembexa

    Fraiser Kansteiner FIERCEPHARMA
    16 May 2022
    Share Share
    Emergent BioSolutions to Acquire from Chimerix, Exclusive WW Rights to TEMBEXA
    Emergent BioSolutions to Acquire from Chimerix, Exclusive WW Rights to TEMBEXA

    16 May 2022

    // PRESS RELEASE

    https://investors.emergentbiosolutions.com/news-releases/news-release-details/emergent-biosolutions-acquire-chimerix-its-exclusive-worldwide

    PRESS RELEASE
    16 May 2022
    Share Share